Table.
Cell type | Locations & frequencies | TCR | Recognized antigen | Activating cytokines | Cytokines produced | Functions in intestinal immunity |
---|---|---|---|---|---|---|
γδ | -Blood (1–10% of T cells in humans) -Gut (25–60% of T cells in humans) -Thymus, Spleen |
Vγ9δ2 (humans) Vδ1 Vδ2 Vγ4δ5 |
-HMB-PP (Vγ9δ2) -MICA, CD1c, lipohexapeptides (Vδ1) -ULBP4 (Vδ2) -EPCR (Vγ4δ5) |
IL-1β IL-23 |
IFN-γ TNF-α IL-17 IL-4 |
-Lysis of infected/stressed cells -Cytokine/chemokine production -B cell help -Priming of αβ T cells -DC maturation -Regulation of stromal cell function |
MAIT | -Blood (1–10% of T cells in humans, ~0.1% in mice) -Gut (LP, PP) -Liver (~30% of T cells in humans) -Lungs |
-Vα7.2-Jα33/12/20, Vβ2/13.2 (humans) -Vα19-Jα33, Vβ6/8 (mice) |
-Vitamin B metabolites | IL-12 IL-18 |
IFN-γ TNF-α IL-17 |
-Anti-bacterial immunity -Cytokine production -Lysis of infected cells |
iNKT | -Blood (0.1–0.2% in humans) -Liver (<1% of T cells in humans, ~10–20 % in mice) -Gut, Lung, Spleen, Bone Marrow, Thymus |
Vα24-Jα18, Vβ11 (humans) Vα14-Jα18, Vβ2/7/8.2 (mice) |
-Endogenous and bacterial-derived glycolipids -α-galactosyl ceramide -β-galactosyl ceramide |
IL-12 IL-18 IL-23 IL-1β IL-7 IL-25 |
Th1 (IFN-γ, TNF-α) Th2 (IL-1, IL-4, IL-13) Th17 (IL-17, IL22) |
-Recognition of endogenous lipid antigens upregulated by DC upon TLR activation -Enhance priming of antigen-specific B and T cell responses -Cytokine production |
ILC3 | -Gut (LP, PP) | N/A | N/A | IL-7 IL-15 SCF (cKit) IL-23 IL-1β |
IL-17 IL-22 |
-Stimulation of antimicrobial peptide RegIIIγ from epithelial cells by ILC-derived IL-22 -Regulating gut CD4 T cell resposnes -Maintenance of epithelial barrier function -Promoting formation of Peyer’s patches and lymph nodes during embryogenesis (LTi) |